Skip to main content
. Author manuscript; available in PMC: 2014 Oct 4.
Published in final edited form as: Toxicology. 2013 Jul 31;0:48–55. doi: 10.1016/j.tox.2013.07.015

Figure 4.

Figure 4

Exposure of mice to 30 mg/kg DE-71 for 30 days shows an alteration in the expression of a presynaptic glutamatergic protein in the frontal cortex. (A) Exposure to DE-71 caused a significant increase in expression of the cortical vGlut compared with untreated animals. (B) In contrast, DE-71 treatment did not have an effect on the expression of the NMDA 2B receptor in the frontal cortex. (C) Representative immunoblots for each protein examined. Data represent mean ± SEM (4-6 animals per treatment group). **Values for animals that are significantly different from controls (p < 0.01).